On Friday, Guardant Health Inc (NASDAQ: GH) was 5.39% up from the session before settling in for the closing price of $30.98. A 52-week range for GH has been $15.81 – $37.04.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 49.27%. When this article was written, the company’s average yearly earnings per share was at 19.46%. With a float of $117.83 million, this company’s outstanding shares have now reached $121.63 million.
Let’s determine the extent of company efficiency that accounts for 1779 employees. In terms of profitability, gross margin is 81.07%, operating margin of -74.41%, and the pretax margin is -74.02%.
Guardant Health Inc (GH) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Guardant Health Inc stocks. The insider ownership of Guardant Health Inc is 4.64%, while institutional ownership is 102.98%. The most recent insider transaction that took place on Nov 18 ’24, was worth 204,722. In this transaction Chief Information Officer of this company sold 7,000 shares at a rate of $29.25, taking the stock ownership to the 17,744 shares. Before that another transaction happened on Nov 18 ’24, when Company’s Officer proposed sale 7,000 for $29.25, making the entire transaction worth $204,722.
Guardant Health Inc (GH) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.64 earnings per share (EPS) during the time that was better than consensus figure (set at -0.75) by 0.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.55 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 19.46% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.20% during the next five years compared to -8.88% drop over the previous five years of trading.
Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators
You can see what Guardant Health Inc (GH) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.85. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.24, a number that is poised to hit -0.78 in the next quarter and is forecasted to reach -2.96 in one year’s time.
Technical Analysis of Guardant Health Inc (GH)
Looking closely at Guardant Health Inc (NASDAQ: GH), its last 5-days average volume was 1.89 million, which is a drop from its year-to-date volume of 2.07 million. As of the previous 9 days, the stock’s Stochastic %D was 70.51%. Additionally, its Average True Range was 1.61.
During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 74.02%, which indicates a significant decrease from 90.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 68.16% in the past 14 days, which was higher than the 62.49% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $24.22, while its 200-day Moving Average is $24.47. However, in the short run, Guardant Health Inc’s stock first resistance to watch stands at $33.79. Second resistance stands at $34.93. The third major resistance level sits at $36.41. If the price goes on to break the first support level at $31.17, it is likely to go to the next support level at $29.69. Now, if the price goes above the second support level, the third support stands at $28.55.
Guardant Health Inc (NASDAQ: GH) Key Stats
There are 123,555K outstanding shares of the company, which has a market capitalization of 4.25 billion. As of now, sales total 563,950 K while income totals -479,450 K. Its latest quarter income was 191,480 K while its last quarter net income were -107,750 K.
